BIOMAT Database Logo BIOMAT Database Logo

Antihypertensive thiadiazoles. 2. Vasodilator activity of some 2-aryl-5-guanidino-1,3,4-thiadiazoles. 1988

S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Department of Medicinal Chemistry, Reckitt and Colman plc, Kingston-upon-Hull, United Kingdom.

Some 2-aryl-5-guanidino-(or N-substituted guanidino)-1,3,4-thiadiazoles and closely related analogues were found to lower blood pressure in metacorticoid (DOCA) hypertensive rats. In the unsubstituted guanidines that exhibited low toxicity, optimum activity resulted when the aryl group was a 2-methylphenyl ring (11). Modifications to the guanidine group did not increase antihypertensive activity, but, in the 2-methylphenyl series, the N-n-butyl- and N-(2-methoxyethyl)guanidines (63 and 78) and the related iminoimidazolidine 93 were of comparable activity to that of the unsubstituted guanidine 11. The iminoimidazolidine 93 showed a somewhat longer duration of action than the guanidine derivatives. Preliminary studies in a pithed rat preparation indicated that these thiadiazole derivatives (11, 63, and 93) lowered blood pressure by a direct relaxant effect on vascular smooth muscle.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003655 Decerebrate State A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358) Decerebrate Posturing,Decorticate Rigidity,Decorticate State,Rigidity, Decerebrate,Rigidity, Decorticate,Decerebrate Posturings,Decerebrate Rigidity,Decerebrate States,Decorticate Rigidities,Decorticate States,Posturing, Decerebrate,Posturings, Decerebrate,Rigidities, Decorticate,State, Decerebrate,States, Decerebrate
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole

Related Publications

S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Synthesis and fungicidal activity of some 5-aryl/aryloxymethyl-2-[5-aryl-3-methyl-1,2,4-triazol-2-yl]-1,3,4-thiadiazoles and 5-aryl/aryloxymethyl-2[5-aryl-2-phenylimino-1,3,4- thiadiazolin-3-yl]-1,3,4-thiadiazoles.
November 2003, Bollettino chimico farmaceutico,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Thiadiazole derivatives. Note IV - Synthesis of some 5-mercapto-1,3,4-thiadiazoles and 5-ethylthio-2-arylamino-1,3,4-thiadiazoles.
July 1979, Bollettino chimico farmaceutico,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
April 2006, European journal of medicinal chemistry,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
[The synthesis of some 5-aryl-2-amino-1,3,4-oxadiazoles and thiadiazoles and preliminary pharmacologic research].
March 1983, Bollettino chimico farmaceutico,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
June 2014, Bioorganic & medicinal chemistry letters,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles.
April 2011, Bioorganic & medicinal chemistry letters,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Multinuclear magnetic resonance studies of 2-aryl-1,3,4-thiadiazoles.
September 2012, Magnetic resonance in chemistry : MRC,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
February 2011, Journal of enzyme inhibition and medicinal chemistry,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Synthesis and hypoglycemic activity of 3-aryl(or pyridyl)-5-alkyl(or aryl)amino-1,3,4-thiadiazoles and some sulfonylurea derivatives of 4H-1,2,4-triazoles.
October 1971, Journal of medicinal chemistry,
S Turner, and M Myers, and B Gadie, and S A Hale, and A Horsley, and A J Nelson, and R Pape, and J F Saville, and J C Doxey, and T L Berridge
Studies on arylfuran derivatives-Part VI. Synthesis, characterization and antibacterial activities of some 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and 6-(5-nitro-2-furyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles.
December 1996, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!